Signing of a collaboration agreement with a major company in the field of animal health.

Quantum Genomics, a biopharmaceutical research company developing new treatments in the field of cardiovascular diseases, has announced that it concluded a collabration agreement with a major company in the field of animal health,  for the QGC101 programme. This agreement aims to continue the development of a drug candidate for the treatment of heart failure in dogs.

Download the PDF - French only